The dietary supplement industry sometimes relies on eye-catching numbers to signal potency and value. But as the National Advertising Division’s (NAD) recent decision in Case No. 7522, Reus Research LLC v. Iron Rock Ventures LLC, makes clear, a big number on the front label must be properly supported, and a fine-print disclaimer buried in the Supplement Facts Panel cannot save a misleading claim.
The Advertising Claims
Iron Rock Ventures LLC (Iron Rock) markets the thinbi NAD+ dietary supplement, a product containing NAD+ (nicotinamide adenine dinucleotide) along with several botanical extracts. The front label of the thinbi NAD+ product prominently displays the statement “8,457MG | 30 CAPSULES.” The same figure appeared in Amazon product page headlines (e.g., “NAD Supplement 8,457 mg Extra Strength…”) and in Instagram posts featuring the product.
Continue reading “Advertising Alert: NAD Scrutinizes Dietary Supplement Dosage Claims”